Novozymes Revenue 2011-2025 | NVZMY

Novozymes revenue for the twelve months ending March 31, 2025 was $2.452B, a 1.76% decline year-over-year.

  • Novozymes annual revenue for 2024 was $4.148B, a 59.61% increase from 2023.
  • Novozymes annual revenue for 2023 was $2.599B, a 4.56% increase from 2022.
  • Novozymes annual revenue for 2022 was $2.486B, a 4.49% increase from 2021.

Novozymes Revenue 2011-2025 | NVZMY

  • Novozymes annual revenue for 2024 was $4.148B, a 59.61% increase from 2023.
  • Novozymes annual revenue for 2023 was $2.599B, a 4.56% increase from 2022.
  • Novozymes annual revenue for 2022 was $2.486B, a 4.49% increase from 2021.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$225.4B
Sherwin-Williams (SHW)$90.7B
Ecolab (ECL)$80.3B
Givaudan SA (GVDNY)$38.9B
SIKA AG - (SXYAY)$37.3B
PPG Industries (PPG)$25.2B
International Flavors & Fragrances (IFF)$16.9B
RPM (RPM)$16B
Symrise AG (SYIEY)$13.5B
Sociedad Quimica Y Minera S.A (SQM)$12.9B
Toray Industries (TRYIY)$10.5B
NewMarket (NEU)$7.5B
FUCHS SE - (FUPBY)$6.7B
Axalta Coating Systems (AXTA)$6.7B
Element Solutions (ESI)$6B
Balchem (BCPC)$5.3B
Nissan Chemical (NNCHY)$5.2B
CSW Industrials (CSWI)$5B
Celanese (CE)$4.9B
Sensient Technologies (SXT)$4.9B
Croda (COIHY)$4.7B
CSW Industrials (CSW)$4.3B
Hawkins (HWKN)$3.5B
H B Fuller (FUL)$3.2B
Perimeter Solutions, SA (PRM)$2.7B
Ashland (ASH)$2.5B
Quaker Houghton (KWR)$2.4B
Ingevity (NGVT)$2B
Minerals Technologies (MTX)$1.9B
DAQO New Energy (DQ)$1.5B